Back to results
US 2024/0050451 A1Published application
Precision cannabinoid therapy formulations and methods of use
AssigneeMDM Enterprise Solutions Inc.
InventorsEleanor DUFF, Kevin SPELMAN, Scott EAGLE
Life of this patent
Estimating the term…
Abstract
Described herein are cannabinoid therapy formulations for sleep, pain, and anxiety conditions. Also provided are methods for improving sleep quality, relieving pain and/or improving anxiety symptoms.
Claims27
-3. (canceled)
A composition comprising:
- (i) about 5 mg to about 80 mg of cannabidiol (CBD), about 1 mg to about 15 mg of cannabinol (CBN), about 1 mg to about 30 mg of cannabigerol (CBG), or any combinations thereof;
- (ii) one or more of the following:
- about 40 mg to 260 mg of Ziziphus spinosa, about 0.1 mg to 4 mg of melatonin, and about 30 mg to about 200 mg of Passiflora incarnata;
- and
- (iii) three or more of the following:
- about 30 mg to about 150 mg of eicosapentaenoic acid (EPA)/docosahexaenoic acid (DHA), about 1 mg to about 80 mg of Citrus reticulata Blanco, about 50 mg to about 200 mg of Withania somnifera, about 30 mg to about 250 mg of Matricaria recutita, about 30 mg to about 220 mg of Lycopus spp., about 50 mg to about 200 mg of Poria cocos, about 5 mg to about 40 mg of Actaea racemosa, about 10 mg to about 150 mg of Pueraria lobata, about 15 mg to about 70 mg of Anemarrhena asphodeloides, about 30 mg to about 120 mg of phosphatidylserine, about 15 mg to about 70 mg of alpha lipoic acid, about 40 mg to about 150 mg of silymarin, about 100 mg to about 280 mg of Schisandra chinensis, about 5 mg to about 50 mg of Cymbopogon flexuosus essential oil, about 10 mg to about 120 mg of Humulus lupulus, about 50 mg to about 200 mg of Grindelia spp., about 30 mg to about 150 mg of Ligusticum wallichii, about 5 mg to about 50 mg of 5-hydroxytryptophan (5-HTP), about 15 mg to about 70 mg of paeonol, about 15 mg to about 150 mg of Panax ginseng, about 20 mg to about 100 mg of Rehmannia glutinosa, about 50 mg to about 200 mg of Polygala tenuifolia, about 20 mg to about 100 mg of Lavendula officinalis, about 50 mg to about 200 mg of Scutellaria lateriflora, about 10 mg to about 150 mg of Pueraria lobata, about 5 mg to about 70 mg of Sceletium tortuosum, about 1 mg to about 15 mg of mixed Tocopherols, about 10 mg to about 200 mg of Magnolia officinalis, about 20 mg to about 100 mg of Piper methysticum, and about 1 mg to about 10 mg of Piper nigrum.
3 more elements
-15. (canceled)
19-20. (canceled)
A composition comprising:
- (i) about 5 mg to about 80 mg of cannabidiol (CBD), about 1 mg to about 30 mg of cannabinol (CBN), and about 1 mg to about 10 mg of Piper nigrum;
- and
- (ii) three or more of the following:
- about 30 mg to about 180 mg of eicosapentaenoic acid (EPA)/docosahexaenoic acid (DHA), about 80 mg to about 300 mg of Curcuma longa, about 30 mg to about 180 mg of Nigella sativa oil, about 1 mg to about 30 mg of Zanthoxylum spp., about 10 mg to about 80 mg of Citrus reticulata Blanco, about 1 mg to about 15 mg of mixed Tocopherols, about 10 mg to about 80 mg of luteolin, about 0.001 mg to about 1 mg of vitamin D, about 150 mg to about 450 mg of Withania somnifera, about 50 mg to about 220 mg of Corydalis yanhusuo, about 1 mg to about 30 mg of Glycyrrhiza glabra, about 1 mg to about 30 mg of Lavandula angustifolia, about 150 mg to about 400 mg of Scutellaria lateriflora, about 30 mg to about 120 mg of coenzyme Q10, about 50 mg to about 250 mg of Angelica sinensis, about 50 mg to about 200 mg of Ligusticum chuanxiong, about 100 mg to about 300 mg of Salix alba, about 1 mg to about 15 mg of zinc, about 100 mg to about 350 mg of Commiphora mukul, about 0.01 mg to about 1 mg of selenium, about 0.001 mg to about 1 mg of iodine, about 10 mg to about 100 mg of Pueraria lobata, about 100 mg to about 350 mg of Viburnum prunfolium, about 50 mg to about 200 mg of Matricaria recutita, about 1 mg to about 15 mg of Lobelia inflata, about 10 mg to about 80 mg of Melissa officinalis, about 10 mg to about 80 mg of Dioscorea villosa, about 10 mg to about 80 mg of Paeonia lactiflora, and about 1 mg to about 200 mg of Zingiber officinalis.
1 more element
22-29. (canceled)
A composition comprising:
- (i) about 5 mg to about 80 mg of cannabidiol (CBD), about 1 mg to about 30 mg of cannabinol (CBN), about 1 mg to about 30 mg of cannabigerol (CBG), or any combinations thereof;
- (ii) one or more of the following:
- about 1 mg to about 10 mg of Piper nigrum or and about 10 mg to about 150 mg of Citrus reticulata Blanco;
- and
- (iii) two or more of the following:
- about 10 mg to about 200 mg Lavandula officinalis, about 10 mg to about 250 mg of Polygala tenuifolia, about 100 mg to about 450 mg of Withania somnifera, about 30 mg to about 150 mg of rutaecarpine, about 30 mg to about 150 mg of Passiflora incarnata, about 100 mg to about 400 mg of Ganoderma lucidum, about 50 mg to about 250 mg of Matricaria recutita, about 10 mg to about 150 mg of Pueraria lobata, about 40 mg to 300 mg of Ziziphus spinosa, about 5 mg to about 100 mg of Sceletium tortuosum, about 5 mg to about 50 mg of Crocus sativus, about 100 mg to about 350 mg of Schisandra chinensis, about 80 mg to about 300 mg of dihydromyricetin, about 5 mg to about 80 mg of 5-hydroxytryptophan (5-HTP), about 50 mg to about 300 mg of Poria cocos, about 20 mg to about 200 mg of Panax ginseng, about 100 mg to about 400 mg of Centella asiatica, about 10 mg to about 200 mg of Magnolia officinalis, about 20 mg to about 100 mg of Piper methysticum, and about 30 mg to about 150 mg of paeonol, about 100 to 200 mg of Rosmarinus officinalis, about 50 to 100 mg of Valeriana officinalis, and about 50 to 100 mg of Theacrine.
3 more elements
33-41. (canceled)
(canceled)
46-48. (canceled)
50-57. (canceled)
Dependencies are inferred from the claim text.